Overall, this study demonstrates that telomerase activators such as TAT2 can represent a new class of therapeutics that enhance immune function at a fundamental cellular level, complement existing drugs for the treatment of HIV / AIDS and a variety of age-related disorders with immune deficiency.
The Journal of Immunology, 2008, engl. PDF Read here